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in the abdominal lymph nodes – in children (57.2%), in the 
mediastinum – in children and patients aged 19-39 (48.2%).
4. Children develop only aggressive NHL variants, which 
also predominate in adults. Aggressive NHLs in adults have 
been predominantly diagnosed in the patients having the pri-
mary tumor focus location in the abdominal and mediastinal 
lymph nodes.  The indolent NHL frequency has been higher 
in case of primary involvement of peripheral lymph nodes in 
patients aged over 60.
5. The frequency of metastases in the bone marrow and 
CNS has been dependent on the location of NHL primary 
focus, morphological variant and age.
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Abstract
Background:  The characteristics of visual evoked potentials (VEP) have been studied in diabetic patients with and without diabetic retinopathy.
Material and methods: The magnetic impulses (2.0 Tl at the height of impulse) have been delivered to the cerebellar surface trans-cranially, using 
Neuro-MS/D, (Russian Federation), and the VEP have been registered every 20 seconds from the moment of the photo stress during one minute.
Results: An increase of the latency period and a reduction of the VEP amplitude have been recorded in the period following the exposure of the macular 
part of the retina to the photo stress.  The VEP characteristics have been restored to the initial level at 74.3 + 3.1 seconds from the photo stress moment 
in the control group, while in the diabetic patients with and without retinopathy this index has been 131.7 + 10.2 and 86.5 + 5.5 seconds respectively. 
In the presence of cerebellar trans-cranial magnetic stimulations (2.0 Тl, 40 impulses) the VEP amplitude depression has been less pronounced, and the 
restoration period of the VEP characteristics shortened to 90.5 + 6.8 seconds in the patients with diabetic retinopathy.
Conclusions: 1. Retinopathy development is linked to a prolonged VEP latency period (P100), lowering N75-P100 amplitude, as well as to the 
enlargement of the recovery period of the retina’s functional capacity in patients suffering from the diabetes mellitus in the presence of photo stress.  2. 
The cerebellar trans-cranial magnetic stimulation facilitates a quicker recovery of the retina’s functional capacity in response to the photo stress in the 
diabetic patients with retinopathy.  3. The periodical cerebellar trans-cranial stimulations may be considered as a prevention method as well as a treatment 
method of diabetic retinopathy.
Key words: diabetic retinopathy, visual evoked potential, trans-cranial magnetic stimulation.
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Introduction
Diabetic retinopathy is one of the causes of the develop-
ment of the acquired blindness at the heart of which there are 
a microcirculatory bloodstream impairment, an increased 
vascular walls ductance and a vascularization development 
that lead to the retinal detachment [8, 10].  Retinopathy 
rarely develops in the first few years of the disease, but this 
pathology is observed in half of the patients who have been 
suffering from diabetes mellitus for 10 years, and in 90% of 
the diabetic patients with a 25-year clinical history.  Due to 
the contemporary treatment methods of diabetes mellitus 
and an increased lifespan of diabetic patients, retinopathy 
has become one of the top-priority concerns among the other 
serious complications of the disease.
It has been lately established that retinopathy pathogenesis 
is linked to the activation of lipid peroxidation and to the 
increased concentration of pro-inflammatory cytokines in 
the retinal structures [10].  On the other hand, raising the 
neuronal brain tissues activity by means of electric stimula-
tion promotes the brain’s anti-oxidative potential [1] and can 
guarantee a neuroprotective effect, inter alia in the case of the 
ischemia-induced neurodegenerative alterations in the retina 
[7].  The objective of this research is to study the recovery 
process of the retina’s functional activity in the patients suf-
fering from diabetes mellitus following a photo stimulation 
(photo stress) test [12], as well as its special features under the 
conditions of cerebellar trans-cranial stimulation [3].
Material and methods
14 practically healthy individuals (the mean age 32.2 + 3.7 
years) and 27 insulin-dependent diabetics (the mean age – 31.2 
+ 4.1 years) have been observed in this research.
All the subjects have provided a written consent to the 
research conduct.  All investigations have been performed in 
accordance to the ethics requirements of the commission on 
ethics at Odessa National Medical University (Animal Care 
and Ethics Committee, 2008/84).
For selecting the control group the following criteria have 
been observed: the intraocular pressure less than 21 milli-
meters of mercury, a preserved acuity of vision, an unaltered 
visual field and an absence of eye diseases and neurological 
disorders.  For the diabetics the criteria have been the fol-
lowing: the intraocular pressure less than 21 millimeters of 
mercury, a correctable acuity of vision (more than 7/10) as 
well as the absence of the signs of the proliferative retinopathy, 
which has been established by means of fluorangiography [12]. 
This method has allowed us dividing the diabetic patients into 
two groups according to the following classification [12]: the 
patients without retinopathy symptoms comprised the first 
group (11 patients); the patients with mild and severe pro-
liferative retinopathy formed the second to fifth groups (16 
patients).  It should be noted that the acuity of vision in dia-
betic patients without retinopathy has been preserved (10/10).
While conducting the research the patients were being 
observed in a dark and soundproof room.  Before recording 
the visually evoked potential (VEP) each subject was adapting 
to the light intensity for 10 minutes until the moment when 
the pupil diameter became equal to 3 mm.  The level of the 
background screen glow was 5 cd/m2.
VEP has been recorded using the adopted technology [2, 
12].  The visual stimuli – chess pattern – has had the contrast 
degree of 70% and the mean luminescence degree of 110 cd/
m2, while the contrast reversion has been carried out with a 
frequency of two times per second.  A subject has been placed 
at a distance of 114 cm from the screen center what has allowed 
a 15-seconds acceptance angle of separate pattern elements 
and a 25о acceptance angle of the screen height.  Only the 
right eye of all the patients has been tested while the left one 
remained closed [2, 12].
The electrodes have been placed at points Oz (the active 
electrode) and Fpz (the reference (recording) electrode); the 
grounding has been fixed on the left arm.  The inter electrode 
resistance has been set at 3 kOhm.  The bioelectric signals 
have been amplified by 20 000 times; the signal transmis-
sion band has comprised 1-100 hz, after that the signals have 
been averaged, and the artifacts have been eliminated for the 
stimulation period [2].  The experiment has been organized 
in the form of not less than two sessions of stimuli exposure; 
during each one 100 answers have been averaged after the 
artifacts elimination.  The VEP analysis period has been 500 
ms.  The visual VEP in this case has included several waves, 
among which three peaks always could be distinguished that 
normally appeared in 75-100 ms and 145 ms.  These peaks 
have had negative (N75), positive (P100) and negative (N145) 
polarities (fig. 1).
Fig. 1.  An induced visual potential in practically healthy patients 
(the upper curve) and in the patients with diabetic retinopathy 
(the lower curve).  A lengthening of the latency period P100 can be 
observed – the distance between the two vertical lines.  A lowering 
of the potential amplitude N75-P100 is also visible.
After the preliminary testing the control VEP have been re-
corded while 40 stimuli responses have been averaged.  These 
recordings served as a basic control of the VEP characteristics. 
A 30-second-long photo stress has been induced using the 200 
W candescent lamp that has been placed at a 20 cm distance 
from the eyeball and has been projected onto the retina as 
a visual field loss with a 6-grades diameter.  As a result, the 
pupil diameter has narrowed up to 2 mm.  Immediately after 
the photo stress exposure VEPs have been recorded and the 
answers have been averaged every 20 s sequentially until the 
moment the resulting answer becomes identical to the basic 
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control record.  The time period till the moment of the VEP 
characteristics recovery has been recorded as the recovery 
time after the photo stress.
The device Neuro-MS/D, (Neurosoft, Russian Federation) 
has been used for the trans-cranial magnetic stimulation 
along with the appropriate coils and 2.0 Tl induction at the 
height of the magnetic-influence impulse.  The coil has been 
positioned on the middle line of the occipital zone in the tan-
gential plane to the cranium surface according to the adopted 
cerebellum stimulation technique [6].  In the control group 
the false stimulation has been carried out positioning the coil 
perpendicularly to the same occipital zone [9].
The research results have been statistically processed 
applying the ANOVA method and the Newman-Keuls test.
Results and discussion
Dynamics of the development of the latency period (LP) 
P100 has revealed that before the photo stress exposure onset 
in the group of patients with diabetic retinopathy this index 
exceeded that in the control group by 27.0% (p < 0.05) (fig. 
2, A).  At the same time, the VEP LP in the group of patients 
without retinopathy has been by 13.9% (p > 0.05) higher 
compared to the control group as well.  In the first 20 s fol-
lowing the stress period, the LP in the group of patients with 
diabetic retinopathy has exceeded that in the control group 
by 33.5% (p < 0.05) and has been higher than that before 
the photo stress exposure by 17.5% (p > 0.05).  A significant 
difference from the control group has persisted until the end 
of the observation.  Meanwhile, the LP recovery to the basic 
value has been recorded in the control group after 74.3 + 3.1 
s, in the group of patients without retinopathy – after 86.5 + 
5.5 s, and in the group of patients with retinopathy – after 
131.7 + 10.2 s (fig. 2, V).
The amplitude N75-Р100 has been by 33.7% (p < 0.05) 
lower in patients without retinopathy than in practically 
healthy patients (fig. 2, B).  In the group of patients with reti-
nopathy such differences comprised 43.5% (p < 0.05).  For the 
first 20 s of post-stress exposure  26.1% (p < 0.05) lowering of 
the amplitude N75-P100 has been observed in comparison 
to the initial background in the control group, while in the 
groups of patients with and without retinopathy it has been 
48.1% (p < 0.05) and 36.1% respectively.  At the same time, 
30.8% (p < 0.05) decrease of the studied index has been re-
corded in the group of patients with retinopathy compared 
to that in the patients without retinopathy (fig. 2, B, II).  The 
significant differences between the groups have persisted for 
60 s of the post-stress observation (fig. 2, B).  Moreover, in the 
40 s of post-stress period the amplitude N75-P100 has been 
lower by 34.8% in the patients without retinopathy than that 
in the control group, and in the group with retinopathy – by 
44.6% (p < 0.05).  The full recovery of the studied index – the 
amplitude N75-P100 – has been observed during the same 
time period as the latency period of P100 recovery.
The effects of trans-cranial magnetic stimulation (TMS) 
influence upon VEP characteristics have been investigated 
in the group of patients suffering from diabetic retinopathy 
(16 patients).
The exposure to the photo stress under the conditions 
of the preceding TMS application (10 impulses) has been 
accompanied with a tendency of the latency period of P100 
shortening, which has been by 5.0% (p > 0.05) shorter in 
the first 20 s of the post-stress exposure than in the group of 
patients with diabetic retinopathy in the absence of the TMS 
(fig. 3).  This index has been relatively lower in the patients 
who have been exposed to the 40 impulses TMS during an 
analogous time period from the moment of the photo stress 
exposure, namely by 33.8% (p < 0.05), and it has been by 15.2% 
(p > 0.05) higher than in practically healthy individuals.  Such 
differences between the observed groups have persisted for 
60 s from the moment of photo stress exposure (fig. 3).
The VEP amplitude in the group of patients with diabetic 
retinopathy, who have undergone 10 impulses cerebellar TMS 
exposure during the first 20 s from the moment of the photo 
stress exposure, has been by 13.1% (p > 0.05) larger than in 
the patients of the given group in the absence of the TMS 
application (fig. 4).  In the subgroup of patients with a larger 
number of TMS impulses (40 impulses) during an analogous 
time period the studied index has been by 17.8% (p < 0.05) 
higher than in the patients without TMS, but still it has been 
lower by 5.7% (p > 0.05) compared with the respective index 
Fig. 2.  Dynamics of the latency period P100 (A) and the amplitude 
N75-P100 (B) after the photo stress.
Legend: abscissa I – before starting the photo stress; II – 20 s; III – 40 
s; IV – 60 s after photo stress exposure; V – complete recovery of the 
studied indices.  Ordinate – the studied indices (seconds and mcV).
# – p < 0.05 in comparison to the control group index; * – p < 0.05 in 
comparison to the index in the group of patients without retinopathy 
(ANOVA+ Newman-Keuls test).
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in the control group.  In the last third of the VEP recording 
period the amplitude N75-P100 in the group that has been 
exposed to 10 impulses exceeded its value in the control 
group by 7.3% (p < 0.05), and in the group with 40 impulses 
application – by 2.1% (p > 0.05).
The recovery period of the studied indices in the group 
of patients with diabetic retinopathy comprised 90.5 + 6.8 s, 
while in the patients without retinopathy this index comprised 
75.4 + 5.9 s (p > 0.05).
Thus, the obtained results have showed that in patients 
suffering from the diabetes mellitus both with and without 
retinopathy there are the following impairments of the VEP 
characteristics observed: lengthening of the latency period of 
P100 and lowering the amplitude N75-P100 in comparison to 
the indices in the control group.  Furthermore, the significant 
changes of the latency period have been recorded only in the 
patients with diabetic retinopathy.
It may be assumed that the described disorders are the 
result of a decreased velocity of the nerve impulse conduc-
tance along the optic nerve [5].  This hypothesis corresponds 
to the research results [5, 10] that show a reduction of the 
electroretinogram amplitude pattern in the absence of the reti-
nopathy signs, which can be explained by a selective damage 
of the ganglion cells and their axons in the central part of the 
retina – by a continuous hyperglycemia.  At the same time, a 
positive correlative relation between VEP changes, peripheral 
diabetic neuropathy, reduction of the central velocity of the 
signal conductance and histological disorders has been estab-
lished [12].  As soon as the development of the optic nerve 
neuropathy has been shown as a result of the ganglion cells 
dysfunction [5, 10], the role of retinopathy in the established 
VEP changes cannot be excluded.  Another fact speaks in 
favor of this assumption, namely, that the latency period of 
P100 in the patients with a proliferative retinopathy has been 
to some extent longer in comparison to that recorded in the 
absence of retinopathy.
The information regarding the functional state of retina 
has been obtained under the conditions of photo stress expo-
sure.  In the control group the light stimulation of the macular 
part of the retina has increased the latency period and lowered 
the VEP amplitude, while the VEP recovery period has been 
recorded during the period up to 80 s from the photo stress 
completion.  It may be assumed that the photo stress impairs 
the ability of the macular photoreceptors to produce the action 
potential after such stimulation.  Meanwhile, a prominent role 
in the VEP recovery seemingly belongs to the photo pigment 
re-synthesis that can be supplied by a sufficient bloodstream 
volume [12].  A positive TMS influence, thus, can be explained 
by the change of metabolism in the retinal tissue that appears, 
probably, due to the antidromic excitation conduction along 
the bisynaptic retinal-cerebellar path [4].  Also rather probable 
is the effect that develops due to the general metabolic TMS 
effects, which induce alterations on the part of the neurotrans-
mitter systems in different brain structures [1, 11].
It should be also noted that the VEP after the photo stress 
in the patients with diabetes and without retinopathy, who 
have preserved vision acuity, and in the absence of the changes 
at fluoroangiography, can indicate the presence of the early 
functional incompetence of the central retinal layers [12].  The 
positive cerebellar TMS effects may point at the possibility of 
this method application for the purpose of prevention of the 
progressive development of neurodegenerative alterations on 
the part of retina in patients suffering from diabetes mellitus.
Fig. 3. Dynamics of changes of the latency period P100 in the 
photo stress test under the conditions of cerebellar trans-cranial 
stimulation application.
Legend: abscissa I – control group (practically healthy individuals); 
II – patients with diabetes and retinopathy; III – effect of 10 cerebellar 
TMS impulses; IV – effect of 40 cerebellar TMS impulses.
Ordinate – investigated indices in % pertained to their corresponing 
levels taken as 100% which have been the following: for the сontrol 
group (I) – data on the VEP without photo stress has been taken as 
100%; for group II – photo stress in patients with diabetes retinopathy 
without TMS has been taken as 100%; for groups III and IV – photo 
stress in patients with diabetes retinopathy without TMS has been 
taken as 100%.
*-p < 0.05 – in comparison to the control group; #-p < 0.05 – in compa-
rison to the index registered in group II – photo stress in patients with 
diabetes retinopathy without TMS (ANOVA+ Newman-Keuls test).
Fig. 4.  Dynamics of the changes of the amplitude of N75-P100 (B) 
in the photo stress test under the conditions of cerebellar trans-
cranial stimulation application.
Legend: the same as in fig. 3.  Sign (-) means magnitude of reduction 
of VEP amplitude compared with the data registered before the photo 
stress in the healthy persons (group I) and the patients with diabetes 
(groups II-IV), retinopathy taken as 100%. 
*-p < 0.05 – in comparison to the control group; #-p < 0.05 – in 
comparison to the index registered in group II – photo stress in the 
patients with diabetes retinopathy without TMS (ANOVA+ Newman-
Keuls test).
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Conclusions
1. The diabetic retinopathy development is linked to a 
prolonged VEP latency period (P100), lowering the N75-P100 
amplitude, as well as to shortening the recovery period of 
retina’s functional capacity after photo stress.
2. The cerebellar trans-cranial magnetic stimulation fa-
cilitates a faster recovery of the retina’s functional capacity in 
response to photo stress in diabetic patients with retinopathy.
3. The periodical cerebellar trans-cranial stimulations may 
be considered as a prevention method as well as a method of 
treatment of diabetic retinopathy.
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Introduction
The first solid phase of radioimmunoassay was reported 
by K.Catt and G.Treagear in the Science Journal at the earlier 
stage of prostate specific antigen (PSA) development [2].  An 
important aspect of the immune response is the production of 
antibodies or immunoglobulins by B-cells (B-lymphocytes). 
Production of anti-prostate specific antigen coated tubes
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Abstract
Background: Immunoassay is an appropriate method for measuring hormones and other protein compounds like a prostate-specific antigen (PSA). 
This antigen is a tumor marker of prostate cancer which can be identified by screening.  Among the numerous available solid phases a coated tube is 
the most popular one.
Material and methods: We have used a monoclonal antibody (mAb) against the PSA.  One of the pairs of monoclonal antibodies has been used for 
preparing the PSA tracer by labeling to radioactive iodine (125I) and the other one – for the coating of polystyrene tubes.  In the solid phase method we 
have used the adsorption technique for coating the monoclonal antibody in polystyrene tubes.  We have used adsorption as a mode of coating and plastic 
tubes as a solid phase.  The reaction takes place between the antigen molecule in the patient serum and the two antibodies (anti-PSA mAb) in the tracer 
and coated tubes, and hence these assays are called solid phase assays.  The determination of PSA is based on the immunoradiometric assay (IRMA). 
The samples or standards are incubated in monoclonal antibody-coated tubes with the second 125I-labelled antibody.  After the incubation period (two 
hours) the liquid contents of the tubes are aspirated and washed.
Results: After running the assay the results have showed a correlation between the concentrations of the serum PSA tested by the locally made coated 
tubes and the commercial ones.  So, we can use the locally made reagents to measure the PSA not only for the laboratories performing a large number 
of tests, but also for the whole country in screening  the prostate cancer which will surely be a cost-effective project.  Finally, as the method is isotopic, it 
is more robust compared to the non-isotopic markers and presents a true immunoassay.
Conclusions: Many solid phases have specific reactive groups which can be activated by a variety of biochemical methods.  This research shows that 
we can manufacture the cost-effective IRMA kits by producing locally the antibody-coated tubes for PSA.  And they can be used in mass screening of 
the prostate cancer for men over 50 in any country.  Finally the same protocol for coating monoclonal antibodies can be used for other tumor markers 
like CEA, CA15-3 and AFP if we have their specific monoclonal antibodies.
Key words: solid phase, coated tubes, immunoassay, prostate-specific antigen.
Serum, when it contains specific antibodies, is referred to as 
antiserum.  All the antibodies have the same basic structure 
of 4 polypeptide chains: two identical “light” chains and two 
identical “heavy” chains linked together by disulfide bonds in 
a distinctive Y conformation. Immunoglobulins are divided 
into classes (IgG, IgM, IgE, IgA and IgD) and subclasses (IgG1, 
